/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

K

Kang Liu

Kyungpook National University(KR)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

45

Papers

57

Citations

2

h-index

2

i10-index

Kang Liu is an academic researcher from Kyungpook National University. The author has contributed to research in topics: Pancreatic and Hepatic Oncology Research & Phagocytosis and Immune Regulation & Cancer Research and Treatments. The author has an h-index of 2, co-authored 39 publications.

ORCID: 0009-0008-5260-8997

Research Topics

Pancreatic and Hepatic Oncology Research Phagocytosis and Immune Regulation Cancer Research and Treatments Cancer Immunotherapy and Biomarkers Peptidase Inhibition and Analysis

Papers by this author

works

Identification of rat prostatic steroid-binding protein as a target antigen of experimental autoimmune prostatitis: implications for prostate cancer therapy

1997 · The Journal of Immunology · 45 citations

https://doi.org/10.4049/jimmunol.159.1.472

Kang Liu Gurkamal Chatta Daniel R. Twardzik Thomas S. Vedvick

FIGURE 2 from Reshaping the Tumor Microenvironment of KRAS<sup>G12D</sup> Pancreatic Ductal Adenocarcinoma with Combined SOS1 and MEK Inhibition for Improved Immunotherapy Response

2024 · 0 citations

https://doi.org/10.1158/2767-9764.26076867

Robert J. Norgard Pratha Budhani Sarah A. O’Brien Youli Xia

FIGURE 1 from Reshaping the Tumor Microenvironment of KRAS<sup>G12D</sup> Pancreatic Ductal Adenocarcinoma with Combined SOS1 and MEK Inhibition for Improved Immunotherapy Response

2024 · 0 citations

https://doi.org/10.1158/2767-9764.26076870

Robert J. Norgard Pratha Budhani Sarah A. O’Brien Youli Xia

FIGURE 1 from Reshaping the Tumor Microenvironment of KRAS<sup>G12D</sup> Pancreatic Ductal Adenocarcinoma with Combined SOS1 and MEK Inhibition for Improved Immunotherapy Response

2024 · 0 citations

https://doi.org/10.1158/2767-9764.26076870.v1

Robert J. Norgard Pratha Budhani Sarah A. O’Brien Youli Xia

FIGURE 3 from Reshaping the Tumor Microenvironment of KRAS<sup>G12D</sup> Pancreatic Ductal Adenocarcinoma with Combined SOS1 and MEK Inhibition for Improved Immunotherapy Response

2024 · 0 citations

https://doi.org/10.1158/2767-9764.26076864

Robert J. Norgard Pratha Budhani Sarah A. O’Brien Youli Xia

Supplementary Figure 7 from Reshaping the Tumor Microenvironment of KRAS<sup>G12D</sup> Pancreatic Ductal Adenocarcinoma with Combined SOS1 and MEK Inhibition for Improved Immunotherapy Response

2024 · 0 citations

https://doi.org/10.1158/2767-9764.26076834

Robert J. Norgard Pratha Budhani Sarah A. O’Brien Youli Xia

Research topics

topics

Pancreatic and Hepatic Oncology Research

Phagocytosis and Immune Regulation

Cancer Research and Treatments

Cancer Immunotherapy and Biomarkers

Peptidase Inhibition and Analysis

Chat about Author

Papers

Chat

Click to start Chat